P
Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary Axiomer™ RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/
Investor insights
Funding rounds participated in
$8.1M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2012
Funding rounds raised
Total raised
$8.1M
from 1 investors over 1 rounds
P
ProQR Therapeutics raised $8.1M on January 11, 2025
Investors: Rett Syndrome Research Trust